BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24424791)

  • 21. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
    Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
    Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of
    Yuan Y; Li J; Xue TL; Hu HR; Lin W; Liu SG; Zhang RD; Zheng HY; Gao C
    Leuk Lymphoma; 2022 Jul; 63(7):1624-1633. PubMed ID: 35129045
    [No Abstract]   [Full Text] [Related]  

  • 23. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.
    Malyukova A; Dohda T; von der Lehr N; Akhoondi S; Corcoran M; Heyman M; Spruck C; Grandér D; Lendahl U; Sangfelt O
    Cancer Res; 2007 Jun; 67(12):5611-6. PubMed ID: 17575125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NOTCH1 mutations are associated with favourable long-term prognosis in paediatric T-cell acute lymphoblastic leukaemia: a retrospective study of patients treated on BCH-2003 and CCLG-2008 protocol in China.
    Gao C; Liu SG; Zhang RD; Li WJ; Zhao XX; Cui L; Wu MY; Zheng HY; Li ZG
    Br J Haematol; 2014 Jul; 166(2):221-8. PubMed ID: 24690100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.
    Ben Abdelali R; Asnafi V; Leguay T; Boissel N; Buzyn A; Chevallier P; Thomas X; Lepretre S; Huguet F; Vey N; Escoffre-Barbe M; Tavernier E; Reman O; Fegueux N; Turlure P; Rousselot P; Cahn JY; Lheritier V; Chalandon Y; Béné MC; Macintyre E; Dombret H; Ifrah N;
    Blood; 2011 Nov; 118(19):5099-107. PubMed ID: 21835957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.
    Jenkinson S; Kirkwood AA; Goulden N; Vora A; Linch DC; Gale RE
    Leukemia; 2016 Jan; 30(1):39-47. PubMed ID: 26220040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
    Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
    J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of FBXW7 and NOTCH1 Mutations on Prognosis of Patients with Adult Acute T Lymphoblastic Leukemia].
    Liu H; Zhu L; Liu YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1294-1300. PubMed ID: 30295241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of complex NOTCH1 mutations on survival in paediatric T-cell leukaemia.
    Mansur MB; Hassan R; Barbosa TC; Splendore A; Jotta PY; Yunes JA; Wiemels JL; Pombo-de-Oliveira MS
    BMC Cancer; 2012 Jan; 12():9. PubMed ID: 22225590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated TRIB2 with NOTCH1 activation in paediatric/adult T-ALL.
    Hannon MM; Lohan F; Erbilgin Y; Sayitoglu M; O'Hagan K; Mills K; Ozbek U; Keeshan K
    Br J Haematol; 2012 Sep; 158(5):626-34. PubMed ID: 22775572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic Value of Recurrent Molecular Genetics and Epigenetics Abnormity in T Lymphoblastic Lymphoma / Leukemia -Review].
    Guan W; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):587-591. PubMed ID: 28446316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NOTCH1 signaling as a therapeutic target in Sézary syndrome.
    van der Fits L; Qin Y; Out-Luiting JJ; Vermeer KG; Whittaker S; van Es JH; Tensen CP; Vermeer MH
    J Invest Dermatol; 2012 Dec; 132(12):2810-7. PubMed ID: 22718117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations of NOTCH1, FBXW7, and prognosis in T-lineage acute lymphoblastic leukemia.
    Mullighan CG
    Haematologica; 2009 Oct; 94(10):1338-40. PubMed ID: 19794079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities.
    Falisi E; Novella E; Visco C; Guercini N; Maura F; Giaretta I; Pomponi F; Nichele I; Finotto S; Montaldi A; Neri A; Rodeghiero F
    Hematol Oncol; 2014 Mar; 32(1):22-30. PubMed ID: 23861036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas.
    Jen KY; Song IY; Banta KL; Wu D; Mao JH; Balmain A
    Blood; 2012 Jan; 119(3):805-9. PubMed ID: 22117044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence.
    Bonn BR; Rohde M; Zimmermann M; Krieger D; Oschlies I; Niggli F; Wrobel G; Attarbaschi A; Escherich G; Klapper W; Reiter A; Burkhardt B
    Blood; 2013 Apr; 121(16):3153-60. PubMed ID: 23396305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia.
    Bardelli V; Arniani S; Pierini V; Pierini T; Di Giacomo D; Gorello P; Moretti M; Pellanera F; Elia L; Vitale A; Storlazzi CT; Tolomeo D; Mastrodicasa E; Caniglia M; Chiaretti S; Ruggeri L; Roti G; Schwab C; Harrison CJ; Almeida A; Pieters T; Van Vlierberghe P; Mecucci C; La Starza R
    Genes Chromosomes Cancer; 2021 Jul; 60(7):482-488. PubMed ID: 33611795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
    Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
    J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic targeting of HES1 transcriptional programs in T-ALL.
    Schnell SA; Ambesi-Impiombato A; Sanchez-Martin M; Belver L; Xu L; Qin Y; Kageyama R; Ferrando AA
    Blood; 2015 Apr; 125(18):2806-14. PubMed ID: 25784680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.
    King B; Trimarchi T; Reavie L; Xu L; Mullenders J; Ntziachristos P; Aranda-Orgilles B; Perez-Garcia A; Shi J; Vakoc C; Sandy P; Shen SS; Ferrando A; Aifantis I
    Cell; 2013 Jun; 153(7):1552-66. PubMed ID: 23791182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.